While many people are aware of the benefits of Modafinil in the treatment of sleep disorders, there are also a number of cautions to be consider when using this drug. While Modafinil is an effective way to increase wakefulness and decrease sleepiness, it has been link to multi-organ hypersensitivity reactions. Take note of this warning before you start taking Modafinil.
Modafinil improves wakefulness
Modafinil is an orally administer benzyhydryl sulfinylacetamide with the molecular formula C15H15NO2S. It is chemically unrelated to amphetamines and methylphenidate, and pharmacologically distinct from both. Despite its chemical nature, modafinil improves wakefulness, with improvements note in a variety of studies in animal models of sleep disorders and in the brains of human volunteers who were sleep deprive.
The drug Modalert was shown to significantly improve wakefulness, including the duration of sleep, MWT, and sleep latency. It was well tolerate, with a low likelihood of tolerance. In the studies of patients with narcolepsy, the drug increased MWT sleep latency and significantly improved wakefulness. While modafinil is not an ideal solution for all patients with sleep disorders, it is safe and effective for many.
Researchers in the United States and Europe have found that modafinil improves wakefulness in people with certain sleep disorders. Sleep apnea and other sleep disorders are mark by excessive diurnal somnolence. It has been approve by the FDA and has been used in Europe since 1988. It’s safe to use and does not have any dietary restrictions. It has been shown to be effective in treating narcolepsy, and the drug is currently available in over-the-counter forms.
It reduces sleepiness
A recent study showed that the cognitive enhancement drug Modalert 200 can be effective in reducing sleepiness. The trial included 211 subjects, compared to 121 subjects in the control group. The researchers found that patients taking modafinil experienced a significant reduction in the number of lapses from baseline to the final visit. They also found that sleepiness was reduce in both groups compare to placebo.
The drug Modvigil increases dopamine in the brain and reduces dopamine reuptake into the nerves, helping people suffering from narcolepsy stay awake during the day. It also reduces periods when people do not breathe while sleeping, which is a common symptom of shift work sleep disorder. However, modafinil is not a cure for sleep disorders. People with sleep disorders should continue to use OSAHS treatments and breathing devices, even if they are well-rested.
It improves quality of life in patients with OSA, SWD, or narcolepsy
Among the many benefits of modafinil, a cognitive-stimulating drug, is its improvement in wakefulness. Clinical trials have found that it improves the quality of life of patients with OSA, SWD, and narcolepsy. However, the drug is not without side effects. The adverse events reported in these studies are often minor.
Clinical trials involving 1500 patients have shown that modafinil can improve quality of life and reduce the severity of OSA, SWD, or necropsy. In a placebo-controlled double-blind trial, 8% of patients discontinued the drug due to an adverse event. Patients were monitor with electrocardiogram intervals and vital signs, and polysomnographic parameters were collect during the daytime to assess the quality of sleep.
In studies that evaluated the efficacy of modafinil for these disorders, the drug reduced excessive sleepiness and significantly improved subjective assessments of sleepiness. Additionally, patients’ quality of life scores improved, and the drug did not significantly affect cardiovascular parameters. Further, patients in extension studies reported improvements in sleepiness, physical function, and general health.
It may cause multi-organ hypersensitivity reactions
The risk of multi-organ hypersensitivity reactions is an important consideration in the use of modafinil, a drug approved by the US Food and Drug Administration for the treatment of narcolepsy, obstructive sleep apnea, and shift work disorder. Fortunately, this drug has a proven track record in the treatment of sleep disorders.
However, the risks of such multi-organ hypersensitivity reactions are unknown. While this drug is well tolerate, patients should be monitor for any symptoms of rash or severe angioedema. If a patient experiences symptoms of angioedema or anaphylaxis, discontinue treatment immediately. Other serious adverse events include mania, hallucinations, suicidal ideation, and aggression. Visit alldayawake.com for more information.
